News

Chondroitin Prevented Joint Destruction in Knee OA

Publish date: March 18, 2011

 

FROM ANNALS OF THE RHEUMATIC DISEASES

Dr. Jean-Pierre Pelletier and Dr. Johanne Martel-Pelletier are consultants for and shareholders in ArthroLab Inc. and ArthroVision Inc. Jean-Pierre Raynauld is a consultant for ArthroVision. Dr. André Beaulieu, Dr. Louis Bassette, and Dr. Frédéric Morin received honoraria from ArthroLab. François Abram is an employee of ArthroVision. Marc Dorais is a consultant for ArthroVision. Dr. Altman had no relevant financial conflicts of interest.

Pages

Recommended Reading

Role of ACE Inhibitors in Preventing Scleroderma Renal Crisis Remains Unclear
MDedge Internal Medicine
Imaging Study Offers New Insight on RA's Pathology
MDedge Internal Medicine
Methotrexate Combination Helps Prolong Anti-TNF Use
MDedge Internal Medicine
Now Let Us Mark the Passing of Gold
MDedge Internal Medicine
Rheumatologists Are Ready to Play
MDedge Internal Medicine
Absolute Risk of Atypical Fractures is Low in Bisphosphonate Users
MDedge Internal Medicine
Belimumab's FDA Approval Marks New Lupus-Treatment Era
MDedge Internal Medicine
Sildenafil Reduced Attack Frequency in Raynaud's
MDedge Internal Medicine
Heart Involvement in Systemic Sclerosis Underappreciated
MDedge Internal Medicine
Without quinine, what should we prescribe for leg cramps?
MDedge Internal Medicine